{"id":"https://openalex.org/W7213456331","doi":"https://doi.org/10.1007/s00066-026-02593-2","title":"Das Tumor\u00f6kosystem als Faktor f\u00fcr Wirkung und Resistenz von Avelumab plus Radiochemotherapie bei Kopf-Hals-Krebs","display_name":"Das Tumor\u00f6kosystem als Faktor f\u00fcr Wirkung und Resistenz von Avelumab plus Radiochemotherapie bei Kopf-Hals-Krebs","alternate_titles":["The tumor ecosystem as a factor influencing efficacy and resistance to avelumab plus radiochemotherapy in head and neck cancer"],"publication_year":2026,"publication_date":"2026-09-17","ids":{"openalex":"https://openalex.org/W7213456331","doi":"https://doi.org/10.1007/s00066-026-02593-2","pmid":"https://pubmed.ncbi.nlm.nih.gov/42752624"},"language":"de","primary_location":{"id":"doi:10.1007/s00066-026-02593-2","doi":"https://doi.org/10.1007/s00066-026-02593-2","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s00066-026-02593-2","pdf_url":"https://link.springer.com/content/pdf/10.1007/s00066-026-02593-2.pdf","source":{"id":"https://openalex.org/S28603624","display_name":"Strahlentherapie und Onkologie","issn_l":"0179-7158","issn":["0179-7158","1439-099X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Strahlentherapie und Onkologie","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W7213456331"],"child_works_count":0,"type":"book-review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007/s00066-026-02593-2.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5006450699","display_name":"Clara M. Reichardt","orcid":"https://orcid.org/0009-0002-1563-843X","observed_orcids":["https://orcid.org/0009-0002-1563-843X"]},"institutions":[{"id":"https://openalex.org/I181369854","display_name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","ror":"https://ror.org/00f7hpc57","country_code":"DE","type":"education","lineage":["https://openalex.org/I181369854"]},{"id":"https://openalex.org/I4210088053","display_name":"Universit\u00e4tsklinikum Erlangen","ror":"https://ror.org/0030f2a11","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210088053"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Clara Reichardt","raw_affiliation_strings":["Bayerisches Zentrum f\u00fcr Krebsforschung, Erlangen, Deutschland","Deutsches Zentrum Immuntherapie, Erlangen, Deutschland","Translationale Strahlenbiologie, Strahlenklinik, Universit\u00e4tsklinikum Erlangen, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg, Erlangen, Deutschland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayerisches Zentrum f\u00fcr Krebsforschung, Erlangen, Deutschland","institution_ids":[]},{"raw_affiliation_string":"Deutsches Zentrum Immuntherapie, Erlangen, Deutschland","institution_ids":[]},{"raw_affiliation_string":"Translationale Strahlenbiologie, Strahlenklinik, Universit\u00e4tsklinikum Erlangen, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg, Erlangen, Deutschland","institution_ids":["https://openalex.org/I181369854","https://openalex.org/I4210088053"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5014743120","display_name":"Tina Jost","orcid":"https://orcid.org/0000-0001-8767-3774","observed_orcids":["https://orcid.org/0000-0001-8767-3774"]},"institutions":[{"id":"https://openalex.org/I181369854","display_name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","ror":"https://ror.org/00f7hpc57","country_code":"DE","type":"education","lineage":["https://openalex.org/I181369854"]},{"id":"https://openalex.org/I4210088053","display_name":"Universit\u00e4tsklinikum Erlangen","ror":"https://ror.org/0030f2a11","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210088053"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Tina Jost","raw_affiliation_strings":["Arbeitsgruppe junge DEGRO der Deutschen Gesellschaft f\u00fcr Radioonkologie e.\u202fV. (DEGRO), Berlin, Deutschland. tina.jost@uk-erlangen.de","Deutsches Zentrum Immuntherapie, Erlangen, Deutschland. tina.jost@uk-erlangen.de","Translationale Strahlenbiologie, Strahlenklinik, Universit\u00e4tsklinikum Erlangen, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg, Erlangen, Deutschland. tina.jost@uk-erlangen.de"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arbeitsgruppe junge DEGRO der Deutschen Gesellschaft f\u00fcr Radioonkologie e.\u202fV. (DEGRO), Berlin, Deutschland. tina.jost@uk-erlangen.de","institution_ids":[]},{"raw_affiliation_string":"Deutsches Zentrum Immuntherapie, Erlangen, Deutschland. tina.jost@uk-erlangen.de","institution_ids":[]},{"raw_affiliation_string":"Translationale Strahlenbiologie, Strahlenklinik, Universit\u00e4tsklinikum Erlangen, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg, Erlangen, Deutschland. tina.jost@uk-erlangen.de","institution_ids":["https://openalex.org/I181369854","https://openalex.org/I4210088053"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5014743120"],"corresponding_institution_ids":["https://openalex.org/I181369854","https://openalex.org/I4210088053"],"apc_list":{"value":4390,"currency":"USD","value_usd":4390},"apc_paid":{"value":4390,"currency":"USD","value_usd":4390},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"202","issue":"11","first_page":"1202","last_page":"1204"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10307","display_name":"Head and Neck Cancer Studies","score":0.7041000127792358,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10307","display_name":"Head and Neck Cancer Studies","score":0.7041000127792358,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.2915000021457672,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11306","display_name":"Nonmelanoma Skin Cancer Studies","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.7760000228881836},{"id":"https://openalex.org/keywords/avelumab","display_name":"avelumab","score":0.9940000176429749},{"id":"https://openalex.org/keywords/chemoradiotherapy","display_name":"chemoradiotherapy","score":0.7860000133514404},{"id":"https://openalex.org/keywords/head-and-neck-squamous-cell-carcinoma","display_name":"head and neck squamous cell carcinoma","score":0.8960000276565552},{"id":"https://openalex.org/keywords/locally-advanced-hnscc","display_name":"locally advanced HNSCC","score":0.7699999809265137},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.7940000295639038},{"id":"https://openalex.org/keywords/treatment-resistance","display_name":"treatment resistance","score":0.5730000138282776},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.9079999923706055},{"id":"https://openalex.org/keywords/pd-l1-expression","display_name":"PD-L1 expression","score":0.878000020980835},{"id":"https://openalex.org/keywords/cisplatin-based-chemoradiotherapy","display_name":"cisplatin-based chemoradiotherapy","score":0.7820000052452087}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9753999710083008},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.4131999909877777},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.3716999888420105},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.32749998569488525},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.2662999927997589},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.26570001244544983},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2612999975681305},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.23489999771118164},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.22439999878406525},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.20990000665187836}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1007/s00066-026-02593-2","doi":"https://doi.org/10.1007/s00066-026-02593-2","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s00066-026-02593-2","pdf_url":"https://link.springer.com/content/pdf/10.1007/s00066-026-02593-2.pdf","source":{"id":"https://openalex.org/S28603624","display_name":"Strahlentherapie und Onkologie","issn_l":"0179-7158","issn":["0179-7158","1439-099X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Strahlentherapie und Onkologie","raw_type":"journal-article"},{"id":"pmid:42752624","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42752624","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]","raw_type":"Journal Article"},{"id":"pmh:oai:open.fau.de:openfau/42211","doi":null,"is_oa":true,"landing_page_url":"https://open.fau.de/handle/openfau/42211","pdf_url":null,"source":{"id":"https://openalex.org/S4306402340","display_name":"OPUS FAU (Kooperativer Bibliotheksverbund Berlin-Brandenburg (KOBV), on behalf of the Universit\u00e4tsbibliothek Erlangen-N\u00fcrnberg)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article"}],"best_oa_location":{"id":"doi:10.1007/s00066-026-02593-2","doi":"https://doi.org/10.1007/s00066-026-02593-2","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s00066-026-02593-2","pdf_url":"https://link.springer.com/content/pdf/10.1007/s00066-026-02593-2.pdf","source":{"id":"https://openalex.org/S28603624","display_name":"Strahlentherapie und Onkologie","issn_l":"0179-7158","issn":["0179-7158","1439-099X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Strahlentherapie und Onkologie","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7213456331.pdf","grobid_xml":"https://content.openalex.org/works/W7213456331.grobid-xml"},"referenced_works_count":6,"referenced_works":["https://openalex.org/W3147500389","https://openalex.org/W4390730449","https://openalex.org/W4403506731","https://openalex.org/W4411407753","https://openalex.org/W7116897653","https://openalex.org/W7117961463"],"related_works":["https://openalex.org/W4411815149","https://openalex.org/W3210814394","https://openalex.org/W2973192456","https://openalex.org/W4387494732","https://openalex.org/W2901437448","https://openalex.org/W7213465084","https://openalex.org/W2897524698","https://openalex.org/W7221650403"],"abstract_inverted_index":{"Hintergrund":[0,84],"der":[1,126],"Arbeit":[2],"Die":[3],"Standardtherapie":[4],"des":[5,9,119],"lokal":[6],"fortgeschrittenen":[7],"Plattenepithelkarzinoms":[8],"Kopf-Hals-Bereichs":[10],"(LA-HNSCC)":[11],"besteht":[12,85],"-abh\u00e4ngig":[13],"von":[14,98],"Resektabilit\u00e4t":[15],"und":[16,24,68,94],"Tumorlokalisation":[17],"-aus":[18],"einer":[19,28,47,99],"multimodalen":[20],"Behandlung":[21],"mit":[22,46],"Operation":[23],"adjuvanter":[25],"(Chemo-)Radiotherapie":[26],"oder":[27,36],"definitiven":[29,48],"Cisplatin-basierten":[30],"Radiochemotherapie.Obwohl":[31],"Immuncheckpoint-Inhibitoren":[32],"die":[33,62,92,97,107],"Therapie":[34],"rezidivierter":[35],"metastasierter":[37],"HNSCC":[38],"grundlegend":[39],"ver\u00e4ndert":[40],"haben,":[41],"konnte":[42],"ihre":[43],"gleichzeitige":[44],"Kombination":[45],"Radiochemotherapie":[49],"im":[50,73,79],"kurativen":[51],"Setting":[52],"bislang":[53],"in":[54,121],"mehreren":[55],"Studien":[56,65],"keinen":[57],"klinischen":[58],"Nutzen":[59],"zeigen;":[60],"lediglich":[61],"k\u00fcrzlich":[63],"publizierten":[64],"GORTEC":[66],"2018-01/NIVOPOST-OP":[67],"Keynote-689":[69],"zeigten":[70],"einen":[71],"Vorteil":[72],"krankheitsfreien":[74],"\u00dcberleben,":[75],"aber":[76],"(noch)":[77],"nicht":[78],"Gesamt\u00fcberleben":[80],"[1,":[81],"2].Vor":[82],"diesem":[83],"weiterhin":[86],"ein":[87],"hoher":[88],"Bedarf":[89],"an":[90],"Biomarkern,":[91],"Patientinnen":[93],"Patienten":[95],"identifizieren,":[96],"immunonkologischen":[100],"Kombinationstherapie":[101],"profitieren":[102],"k\u00f6nnten.Da":[103],"etablierte":[104],"Marker":[105],"wie":[106],"PD-L1-Expression":[108],"hierf\u00fcr":[109],"nur":[110],"eine":[111],"begrenzte":[112],"Vorhersagekraft":[113],"besitzen,":[114],"r\u00fccken":[115],"zunehmend":[116],"umfassendere":[117],"Analysen":[118],"Tumor\u00f6kosystems":[120],"den":[122],"Fokus":[123],"translationaler":[124],"Forschung.In":[125],"JAVELIN-Head-and-Originalpublikation":[127],"Riaz,":[128],"N.,":[129]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7213456331","counts_by_year":[],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2026-09-17T00:00:00"}
